{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:39:41Z","timestamp":1792683581281,"version":"4.5.0"},"reference-count":0,"publisher":"The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS","issue":"7","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turkish Journal of Medical Sciences"],"abstract":"<jats:p>Background\/aim: Effective management of heart failure involves evidence-based use of multiple medications and their combinations. Furthermore, dosage escalation of the recommended medications is advised. In cases of advanced heart failure, long-term mechanical assistance devices or heart transplantation surgery may be necessary. The socio-economic situation creates unequal chances for people to access these treatments.The study aimed to analyze and compare medical and advanced heart failure treatments recommended by guidelines across various regions in T\u00fcrkiye.Materials and methods: About 85 million citizen medical treatment records were utilized between January 1, 2016, and December 31, 2022. Medical and heart replacement treatment opportunities used in heart failure in T\u00fcrkiye were evaluated in the general population and different geographical regions.Results: According to this study, beta-blockers were the most commonly prescribed medication for heart failure in T\u00fcrkiye. This was followed by angiotensin-converting enzyme inhibitors (ACEi) at 44% and mineralocorticoid receptor antagonists (MRA) at 38.9%. However, only 0.6% of patients used angiotensin receptor blocker-neprilysin inhibitors (ARNI). Despite the high incidence of diabetes mellitus among heart failure patients, only 11% used sodium-glucose cotransporter two inhibitors (SGLT-2i). The study also found that using an Implantable Cardioverter Defibrillator (ICD) was 0.8%, and Cardiac Resynchronization Therapy (CRT) was 0.3% among all intracardiac device treatments. Heart replacement therapies, cardiac transplantation surgery, and long-term left ventricle-assisted device (LVAD) surgery had very low rates.Conclusion: The use of guideline-directed medical therapy is not optimal in T\u00fcrkiye. Also, it differs within different geographical regions. It is a fact that heart transplant or LVAD surgery, CRT, and ICD implantation rates in T\u00fcrkiye are significantly lower than in developed countries, regardless of geographical regions.<\/jats:p>","DOI":"10.55730\/1300-0144.5933","type":"journal-article","created":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T03:12:59Z","timestamp":1734837179000},"page":"1470-1477","source":"Crossref","is-referenced-by-count":1,"title":["Medical and advanced heart failure therapies in T\u00fcrkiye"],"prefix":"10.55730","volume":"54","author":[{"given":"SANEM","family":"NALBANTG\u0130L","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EMRE","family":"DEM\u0130R","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AHMET","family":"\u00c7EL\u0130K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130NC\u0130 TU\u011e\u00c7E","family":"\u00c7\u00d6LL\u00dcO\u011eLU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NA\u0130M","family":"ATA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MEHMET B\u0130RHAN","family":"YILMAZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANIL","family":"\u015eAH\u0130N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u0130LEK","family":"URAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MUSTAFA MAH\u0130R","family":"\u00dcLG\u00dc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EM\u0130NE ARZU","family":"KANIK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LALE D\u0130N\u00c7","family":"ASARCIKLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y\u00dcKSEL","family":"\u00c7AVU\u015eO\u011eLU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SELDA","family":"MURAT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eUAY\u0130P","family":"B\u0130R\u0130NC\u0130","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"34691","published-online":{"date-parts":[[2024,1,1]]},"container-title":["Turkish Journal of Medical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:48:42Z","timestamp":1792680522000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.tubitak.gov.tr\/medical\/vol54\/iss7\/8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":0,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,12,13]]}},"URL":"https:\/\/doi.org\/10.55730\/1300-0144.5933","relation":{},"ISSN":["1300-0144"],"issn-type":[{"value":"1300-0144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}